Institute of Medical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Biomaterials. 2010 May;31(14):3793-803. doi: 10.1016/j.biomaterials.2010.01.120. Epub 2010 Feb 19.
Several tissue engineering approaches for the treatment of cardiovascular diseases are based on a xenogeneic extracellular matrix. However, the application of engineered heart valves has failed in some patients, causing severe signs of inflammation by so far undetermined processes. Therefore we investigated the immune-mediated responses to porcine valve matrices (native, decellularized and glutaraldehyde-fixed) and to purified xenogeneic extracellular matrix proteins (ECMp). The induction of human immune responses in vitro was evaluated by analyzing the co-stimulatory effects of matrices and ECMp collagen and elastin on the proliferation of immune cell sub-populations via CFSE-based proliferation assays. The pattern of cytokine release was also determined. In porcine matrix punches we demonstrated strong immune responses with the native as well as the decellularized type, in contrast to attenuated effects with glutaraldehyde-fixed matrices. Furthermore, our results indicate that collagen type I (porcine and human) and human elastin were able to elicit proliferation in co-stimulation with anti-CD3 antibody, accompanied by a strong release of Th1 cytokines (IFN-gamma, TNF-alpha). In contrast, porcine elastin did not elicit any response at all. This low immunogenic potential of porcine elastin suggests its suitability for the creation of new tissue engineering heart valve scaffolds in the future.
几种用于治疗心血管疾病的组织工程方法基于异种细胞外基质。然而,工程心脏瓣膜在一些患者中的应用已经失败,导致目前仍不确定的过程中出现严重的炎症迹象。因此,我们研究了对猪瓣膜基质(天然、去细胞和戊二醛固定)和纯化的异种细胞外基质蛋白(ECMp)的免疫介导反应。通过 CFSE 增殖测定分析基质和 ECMp 胶原和弹性蛋白对免疫细胞亚群增殖的共刺激作用,评估体外诱导人免疫反应的情况。还确定了细胞因子释放的模式。在猪基质冲压片中,我们证明了天然型和去细胞型都具有强烈的免疫反应,而戊二醛固定型则反应较弱。此外,我们的结果表明,I 型胶原(猪和人)和人弹性蛋白在与抗 CD3 抗体共刺激时能够引起增殖,并伴有 Th1 细胞因子(IFN-γ、TNF-α)的强烈释放。相比之下,猪弹性蛋白根本没有引起任何反应。猪弹性蛋白的这种低免疫原性表明其适合未来用于创建新的组织工程心脏瓣膜支架。